Xylem Inc. (XYL) Key Metrics
XYL valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $24.29B
- Enterprise value
- $27.15B
- P/E (TTM)
- 24.8 10-yr median 36.4
- Forward P/E
- 17.4
- PEG ratio
- 1.32
- Price / sales
- 2.7 10-yr median 3.3
- Price / book
- 2.4 10-yr median 4.6
- EV / EBITDA
- 14.6 10-yr median 20.6
- Dividend yield
- 1.65% $1.72 a year
- Beta
- 0.99
XYL key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsXYL valuation Price multiples at each fiscal year-end price.
XYL returns How much profit the business earns on the capital it uses.
XYL per-share figures Results divided by the shares outstanding at year-end.
XYL financial health Debt, liquidity and how easily interest is covered.
XYL efficiency & capital use Working capital cycle and where the cash goes.
XYL valuation history
XYL returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
XYL debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
XYL cash returned to shareholders
XYL price vs earnings per share
XYL key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $33.23B | $28.25B | $24.95B | $20.01B | $21.77B | $18.43B | $14.28B | $12.08B | $12.34B | $8.91B |
| Enterprise value | $33.81B | $29.25B | $26.32B | $21.02B | $22.93B | $19.71B | $15.93B | $14.09B | $14.12B | $11.08B |
| P/E ratio | 34.7 | 31.7 | 41.0 | 56.4 | 51.0 | 72.6 | 35.6 | 22.0 | 37.3 | 34.3 |
| Price / sales | 3.7 | 3.3 | 3.4 | 3.6 | 4.2 | 3.8 | 2.7 | 2.3 | 2.6 | 2.4 |
| Price / book | 2.9 | 2.7 | 2.5 | 5.7 | 6.7 | 6.2 | 4.8 | 4.4 | 4.9 | 4.1 |
| Price / free cash flow | 36.5 | 30.0 | 44.1 | 51.6 | 66.0 | 28.8 | 23.3 | 34.6 | 23.9 | 23.9 |
| Price / operating cash flow | 26.8 | 22.4 | 29.8 | 33.6 | 40.5 | 22.4 | 17.0 | 20.6 | 18.0 | 17.9 |
| EV / sales | 3.7 | 3.4 | 3.6 | 3.8 | 4.4 | 4.0 | 3.0 | 2.7 | 3.0 | 2.9 |
| EV / EBITDA | 18.9 | 17.3 | 23.5 | 28.9 | 27.6 | 32.1 | 21.5 | 15.2 | 18.1 | 19.8 |
| EV / free cash flow | 37.2 | 31.1 | 46.5 | 54.2 | 69.5 | 30.7 | 26.0 | 40.4 | 27.4 | 29.7 |
| Earnings yield | 2.9% | 3.2% | 2.4% | 1.8% | 2.0% | 1.4% | 2.8% | 4.5% | 2.7% | 2.9% |
| Free cash flow yield | 2.7% | 3.3% | 2.3% | 1.9% | 1.5% | 3.5% | 4.3% | 2.9% | 4.2% | 4.2% |
| Dividend yield | 1.2% | 1.2% | 1.2% | 1.1% | 0.9% | 1.0% | 1.2% | 1.3% | 1.1% | 1.3% |
| Shareholder yield (dividends + buybacks) | 1.2% | 1.3% | 1.3% | 1.3% | 1.2% | 1.4% | 1.5% | 1.7% | 1.3% | 1.3% |
| Share price at fiscal year-end | $136.18 | $116.02 | $114.36 | $110.57 | $119.92 | $101.79 | $78.79 | $66.72 | $68.20 | $49.52 |
| Per share | ||||||||||
| Revenue per share | $37.03 | $35.16 | $33.75 | $30.51 | $28.62 | $26.92 | $28.97 | $28.75 | $26.02 | $20.95 |
| Earnings per share | $3.92 | $3.66 | $2.79 | $1.96 | $2.35 | $1.40 | $2.21 | $3.03 | $1.83 | $1.44 |
| Operating cash flow per share | $5.09 | $5.19 | $3.84 | $3.29 | $2.96 | $4.55 | $4.63 | $3.24 | $3.79 | $2.76 |
| Free cash flow per share | $3.73 | $3.87 | $2.59 | $2.14 | $1.82 | $3.54 | $3.38 | $1.93 | $2.85 | $2.07 |
| Cash per share | $6.06 | $4.60 | $4.67 | $5.22 | $7.43 | $10.35 | $4.00 | $1.63 | $2.29 | $1.71 |
| Book value per share | $47.05 | $43.70 | $46.59 | $19.31 | $17.77 | $16.39 | $16.32 | $15.28 | $13.92 | $12.17 |
| Tangible book value per share | $3.59 | $1.16 | $0.23 | −$0.86 | −$3.21 | −$5.41 | −$5.83 | −$7.95 | −$7.83 | −$9.14 |
| Dividends per share | $1.60 | $1.44 | $1.37 | $1.20 | $1.12 | $1.04 | $0.96 | $0.84 | $0.72 | $0.62 |
| Capex per share | $1.36 | $1.32 | $1.24 | $1.15 | $1.15 | $1.01 | $1.25 | $1.31 | $0.94 | $0.69 |
| Debt per share | $8.45 | $8.73 | $10.95 | $10.77 | $13.82 | $17.38 | $13.12 | $12.74 | $12.16 | $13.77 |
| Shares outstanding | 244.0M | 243.5M | 218.2M | 181.0M | 181.5M | 181.1M | 181.2M | 181.1M | 180.9M | 180.0M |
| Change in shares outstanding | +0.2% | +11.6% | +20.6% | −0.3% | +0.2% | −0.1% | +0.1% | +0.1% | +0.5% | −0.9% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | 8.7% | 8.6% | 8.9% | 10.6% | 13.8% | 8.6% | 14.0% | 20.8% | 14.1% | 12.2% |
| Return on invested capital (ROIC) | 8.3% | 7.1% | 7.8% | 11.3% | 11.3% | 7.4% | 10.0% | 13.5% | 9.0% | 8.8% |
| Return on assets (ROA) | 5.6% | 5.5% | 5.1% | 4.4% | 5.0% | 3.1% | 5.4% | 7.8% | 5.0% | 4.7% |
| Return on tangible assets | 13.6% | 14.5% | 10.2% | 8.3% | 9.6% | 5.3% | 10.8% | 18.2% | 11.3% | 9.8% |
| Free cash flow margin | 10.1% | 11.0% | 7.7% | 7.0% | 6.4% | 13.1% | 11.7% | 6.7% | 11.0% | 9.9% |
| Income quality (OCF / net income) | 1.30 | 1.42 | 1.37 | 1.68 | 1.26 | 3.24 | 2.09 | 1.07 | 2.07 | 1.91 |
| Financial health | ||||||||||
| Total debt | $2.06B | $2.12B | $2.39B | $1.95B | $2.51B | $3.15B | $2.38B | $2.31B | $2.20B | $2.48B |
| Cash & short-term investments | $1.48B | $1.12B | $1.02B | $944.0M | $1.35B | $1.88B | $724.0M | $296.0M | $414.0M | $308.0M |
| Net debt | $584.0M | $1.00B | $1.37B | $1.00B | $1.16B | $1.27B | $1.65B | $2.01B | $1.79B | $2.17B |
| Debt / equity | 0.18 | 0.20 | 0.24 | 0.56 | 0.78 | 1.06 | 0.80 | 0.83 | 0.87 | 1.13 |
| Debt / assets | 0.12 | 0.13 | 0.15 | 0.25 | 0.30 | 0.36 | 0.31 | 0.32 | 0.32 | 0.38 |
| Net debt / EBITDA | 0.33 | 0.59 | 1.22 | 1.38 | 1.39 | 2.08 | 2.23 | 2.17 | 2.28 | 3.87 |
| Current ratio | 1.62 | 1.75 | 1.76 | 1.89 | 2.27 | 1.80 | 1.63 | 1.51 | 1.88 | 1.36 |
| Quick ratio | 1.28 | 1.33 | 1.30 | 1.39 | 1.77 | 1.52 | 1.27 | 1.08 | 1.41 | 0.98 |
| Interest coverage | 42.2 | 22.9 | 13.3 | 12.4 | 7.7 | 4.8 | 7.3 | 8.0 | 6.7 | 5.8 |
| Working capital | $1.78B | $1.76B | $1.68B | $1.42B | $1.77B | $1.57B | $949.0M | $705.0M | $971.0M | $491.0M |
| Invested capital | $12.06B | $11.65B | $11.54B | $4.50B | $4.39B | $4.24B | $4.61B | $4.78B | $4.30B | $4.36B |
| Tangible asset value | $1.15B | $519.0M | $60.0M | −$146.0M | −$582.0M | −$971.0M | −$1.05B | −$1.43B | −$1.42B | −$1.65B |
| Net current asset value | −$1.24B | −$1.52B | −$2.05B | −$1.44B | −$1.89B | −$2.25B | −$2.29B | −$2.35B | −$2.27B | −$2.45B |
| Graham number | $64.44 | $59.95 | $54.10 | $29.19 | $30.67 | $22.74 | $28.51 | $32.29 | $23.94 | $19.89 |
| Graham net-net per share | −$10.64 | −$11.27 | −$14.65 | −$12.62 | −$14.52 | −$16.17 | −$16.40 | −$16.97 | −$16.30 | −$17.14 |
| Capital allocation | ||||||||||
| Dividends paid | $391.0M | $350.0M | $299.0M | $217.0M | $203.0M | $188.0M | $174.0M | $152.0M | $130.0M | $112.0M |
| Share buybacks (net) | $15.0M | $20.0M | $25.0M | $52.0M | $68.0M | $61.0M | $40.0M | $59.0M | $25.0M | $4.0M |
| Dividend payout ratio | 40.9% | 39.3% | 49.1% | 61.1% | 47.5% | 74.0% | 43.4% | 27.7% | 39.3% | 43.1% |
| Dividends + buybacks / free cash flow | 44.6% | 39.3% | 57.2% | 69.3% | 82.1% | 38.8% | 34.9% | 60.5% | 30.0% | 31.1% |
| Capex / revenue | 3.7% | 3.7% | 3.7% | 3.8% | 4.0% | 3.8% | 4.3% | 4.6% | 3.6% | 3.3% |
| Capex / operating cash flow | 26.7% | 25.4% | 32.4% | 34.9% | 38.7% | 22.2% | 26.9% | 40.4% | 24.8% | 24.9% |
| Capex / depreciation | 0.58 | 0.57 | 0.62 | 0.88 | 0.85 | 0.73 | 0.88 | 0.91 | 0.73 | 0.82 |
| Stock-based compensation / revenue | 0.6% | 0.7% | 0.8% | 0.7% | 0.6% | 0.5% | 0.6% | 0.6% | 0.4% | 0.5% |
| R&D / revenue | 2.5% | 2.7% | 3.2% | 3.7% | 3.9% | 3.8% | 3.6% | 3.6% | 3.8% | 2.9% |
| SG&A / revenue | 21.3% | 22.3% | 23.9% | 24.8% | 22.7% | 23.4% | 22.1% | 22.3% | 23.1% | 24.2% |
| Efficiency | ||||||||||
| Days sales outstanding | 69.2 | 70.0 | 67.2 | 67.7 | 65.9 | 73.3 | 71.9 | 69.6 | 69.8 | 77.0 |
| Days of inventory on hand | 65.0 | 68.7 | 71.4 | 79.6 | 71.3 | 65.7 | 64.6 | 64.2 | 66.8 | 75.4 |
| Days payables outstanding | 66.3 | 67.3 | 66.4 | 72.3 | 68.5 | 69.9 | 67.4 | 65.1 | 64.3 | 62.8 |
| Cash conversion cycle (days) | 67.9 | 71.4 | 72.2 | 75.0 | 68.7 | 69.2 | 69.1 | 68.7 | 72.3 | 89.7 |
| Receivables turnover | 5.27 | 5.21 | 5.43 | 5.39 | 5.54 | 4.98 | 5.08 | 5.24 | 5.23 | 4.74 |
| Payables turnover | 5.51 | 5.42 | 5.50 | 5.05 | 5.33 | 5.22 | 5.42 | 5.61 | 5.68 | 5.81 |
| Inventory turnover | 5.62 | 5.31 | 5.12 | 4.59 | 5.12 | 5.55 | 5.65 | 5.69 | 5.46 | 4.84 |
| Asset turnover | 0.53 | 0.53 | 0.61 | 0.68 | 0.61 | 0.59 | 0.70 | 0.74 | 0.71 | 0.68 |
| Average receivables | $1.71B | $1.64B | $1.36B | $1.02B | $938.0M | $979.5M | $1.03B | $993.5M | $899.5M | $796.0M |
| Average payables | $1.01B | $987.0M | $845.5M | $681.0M | $604.0M | $583.0M | $591.5M | $567.5M | $503.0M | $397.5M |
| Average inventory | $989.5M | $1.01B | $908.5M | $749.5M | $629.0M | $548.5M | $567.0M | $559.5M | $523.0M | $477.5M |
| Intangibles / total assets | 60.1% | 62.8% | 62.8% | 45.9% | 46.0% | 45.1% | 52.0% | 58.3% | 57.4% | 59.2% |
Computed from XYL's annual financial statements (latest annual report filed February 25, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
XYL valuation and financial ratios
At the end of fiscal 2025 (December 31, 2025), Xylem traded at 34.7 times earnings, against a 10-year median of 36.4. Based on the latest twelve months, the trailing P/E is 24.8 and the forward P/E is 17.4. Xylem earned a return on equity of 8.7% and a return on invested capital of 8.3% in fiscal 2025. It ended the year with $2.1 billion of debt and $1.5 billion in cash and short-term investments, net debt of $584.0 million. It returned $406.0 million to shareholders: $391.0 million in dividends and $15.0 million in share buybacks, 45% of free cash flow. The share count rose 35.6% from 180.0M to 244.0M over 9 years.
See the XYL income statement, the XYL chart for price history, or the XYL stock overview for the latest quote and news.
XYL key metrics FAQ
What is Xylem's P/E ratio?
Xylem's trailing P/E ratio is 24.8 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 17.4. At the end of fiscal 2025 it was 34.7, compared with a 10-year median of 36.4.
What is Xylem's EV/EBITDA?
Xylem's enterprise value was 18.9 times EBITDA at the end of fiscal 2025 (enterprise value $33.8 billion, EBITDA $1.8 billion); the current EV/EBITDA is 14.6.
What is Xylem's return on equity?
Xylem's return on equity (ROE) was 8.7% in fiscal 2025: net income of $957.0 million on average shareholders' equity of $11.1 billion.
What is Xylem's ROIC?
Xylem's return on invested capital was 8.3% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Xylem have?
Xylem had total debt of $2.1 billion at the end of fiscal 2025, a debt-to-equity ratio of 0.18 and $584.0 million of net debt (0.33 times EBITDA).
What is Xylem's dividend yield?
Xylem's forward dividend yield is 1.65%. Xylem paid $391.0 million in dividends in fiscal 2025 ($1.60 per share), a payout ratio of 40.9%.
Does Xylem buy back its shares?
Yes. Xylem spent $15.0 million on net share repurchases in fiscal 2025 Shares outstanding changed +0.2% over the year, to 244.0M..
What is Xylem's free cash flow yield?
Xylem generated $910.0 million of free cash flow in fiscal 2025, a free cash flow yield of 2.7% on its market value at year-end ($33.2 billion).
What is Xylem's current ratio?
Xylem's current ratio was 1.62 at the end of fiscal 2025: current assets were 1.62 times current liabilities.